Replies to post #64723 on Biotech Values

[zipjet]

>>Is the MS market expanding that much?

There has been a significant shift by neurologists who more than ever want to treat MS early.

Tysabri offers a new and effective treatment - so effective that I expect it to become the gold standard of treating RRMS - provided PML does not prove a significant foe.

zip